Subscribe To
Phathom Pharmaceuticals Presents New Data at Digestive Disease Week® (DDW) 2023
Higher H. pylori eradication rates demonstrated with vonoprazan-based regimens vs. lansoprazole triple therapy, regardless of different baseline demographics and clinical characteristics Meta-analysis shows potassium-competitor acid blockers (PCABs), including vonoprazan, provide a longer duration of pH >4, higher predicted Erosive GERD healing rates, and lower probabilities of failure to achieve healing FLORHAM PARK, N.J., May 09, […] The post Phathom Pharmaceuticals Presents New Data at Digest...
Read More
Posted: May 9 2023, 12:00
Author Name: forextv
Views: 081750